Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Behavioral Genetics and Its Designs01:23

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative proteomic analysis of human placenta derived from assisted reproductive technology.

Proteomics·2008
Same author

Impedance studies of bio-behavior and chemosensitivity of cancer cells by micro-electrode arrays.

Biosensors & bioelectronics·2008
Same author

[Preparation of the polypeptide antibody against human transcriptional factors TFDP1 and TFDP3].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2008
Same author

Oleanolic acid derivative NPLC441 potently stimulates glucose transport in 3T3-L1 adipocytes via a multi-target mechanism.

Biochemical pharmacology·2008
Same author

Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination.

Molecular cell·2008
Same author

Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology·2008

Related Experiment Video

Updated: May 9, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

A novel bayesian graphical model for genome-wide multi-SNP association mapping.

Yu Zhang1

  • 1Department of Statistics, The Pennsylvania State University, University Park, Pennsylvania 16802, USA. yuzhang@stat.psu.edu

Genetic Epidemiology
|December 1, 2011
PubMed
Summary

This study introduces a novel Bayesian method for joint multivariant association mapping in genome-wide studies. The approach enhances power and specificity, accurately identifying primary disease variants and filtering out redundant linkage disequilibrium effects.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Related Experiment Videos

Last Updated: May 9, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Area of Science:

  • Genetics
  • Statistical Genetics
  • Bioinformatics

Background:

  • Current disease association mapping often uses single-variant tests, which lack power for joint mutations and gene interactions.
  • Ignoring variant dependence in genome-wide association studies (GWAS) leads to redundant findings.
  • Simultaneous multivariant association mapping is crucial for large-scale genetic studies.

Purpose of the Study:

  • To develop a novel Bayesian method for automatic detection of multivariant joint association in genome-wide case-control studies.
  • To improve power and specificity compared to existing association mapping tools.
  • To accurately pinpoint primary disease variants by accounting for linkage disequilibrium (LD).

Main Methods:

  • A joint probabilistic model is fitted to the entire dataset for simultaneous variant identification.
  • The method dynamically accounts for strong linkage disequilibrium (LD) between variants.
  • Secondary associations due to LD effects are filtered out to identify primary disease variants.

Main Results:

  • The novel Bayesian method demonstrated improved power and specificity over existing tools.
  • Applied to an inflammatory bowel disease (IBD) dataset, it identified all known IBD loci and recovered two missed loci.
  • Two novel interchromosome interactions were detected: STAT3-PARD6G and DLG5-5p14 region, and validated in an independent study.

Conclusions:

  • The developed Bayesian method offers a powerful and specific approach for multivariant association mapping in GWAS.
  • It effectively identifies primary disease variants, filters LD effects, and improves resolution in pinpointing genetic associations.
  • The method successfully identified known and novel loci and interactions for IBD, highlighting its utility in genetic research.